BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 814505)

  • 1. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
    Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
    Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
    de Vries HR; Bijvoet OL; Froeling PG
    J Endocrinol; 1975 Mar; 64(3):51P. PubMed ID: 805820
    [No Abstract]   [Full Text] [Related]  

  • 4. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical, biological and histological effects of ethane-1-hydroxy 1, 1-diphosphonate (EDHP) in Paget's disease].
    Meunier P; Chapuy MC; Courpron P; Vignon E; Edouard C; Bernard J
    Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):699-705. PubMed ID: 817385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR; Bijvoet OL
    Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
    [No Abstract]   [Full Text] [Related]  

  • 8. [Non-hormonal drug treatment in Paget's disease].
    Ryckewaert A; Lemaire V; Tubiana M
    Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):693-8. PubMed ID: 131365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
    Hosking DJ; Bijvoet OL
    Calcif Tissue Res; 1976 Aug; 21 Suppl():321-6. PubMed ID: 821599
    [No Abstract]   [Full Text] [Related]  

  • 10. Paget's bone disease treated with diphosphonate and calcitonin.
    Hosking DJ; Bijvoet OL; van Aken J; Will EJ
    Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphosphonates in Paget's disease.
    Russell RG; Smith R; Preston C; Walton RJ; Woods CG
    Lancet; 1974 May; 1(7863):894-8. PubMed ID: 4133419
    [No Abstract]   [Full Text] [Related]  

  • 12. [EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of polyosseous Paget disease].
    Kovarik J; Niebauer B; Woloszczuk W; Frühwald F; Kolbe H
    Wien Klin Wochenschr; 1985 Mar; 97(7):311-5. PubMed ID: 3922124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
    Stein I; Shapiro B; Ostrum B; Beller ML
    Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M; Khairi A; Johnston C
    Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
    [No Abstract]   [Full Text] [Related]  

  • 15. Diphosphonate treatment of Paget's disease of bone. A correlated metabolic, calcium kinetic and morphometric study.
    Guncaga J; Lauffenburger T; Lentner C; Dambacher MA; Haas HG; Fleisch H; Olah AJ
    Horm Metab Res; 1974 Jan; 6(1):62-9. PubMed ID: 4819289
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term therapy of Paget's disease of bone with EHDP.
    Siris ES; Canfield RE; Jacobs TP; Baquiran DC
    Arthritis Rheum; 1980 Oct; 23(10):1177-84. PubMed ID: 6775644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone tissue in Paget's disease treated by ethane-1, hydroxy-1, 1 diphosphonate (EHDP). Structure, ultrastructure, and immunocytology.
    Basle MF; Rebel A; Renier JC; Audran M; Filmon R; Malkani K
    Clin Orthop Relat Res; 1984 Apr; (184):281-8. PubMed ID: 6423333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of Paget's bone disease with sodium ethidronate.
    Fromm GA; Schajowicz F; Casco C; Ghiringhelli G; Mautalen CA
    Am J Med Sci; 1979; 277(1):29-37. PubMed ID: 106728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
    Davoine GA; Jung A; Courvoisier B
    Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paget disease of the skeleton. Internal medicine aspects].
    Ziegler R; Baldauf G
    Radiologe; 1984 Sep; 24(9):401-7. PubMed ID: 6238341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.